On this page
Nystatin
Overview
Active ingredients
Source: NDC DirectoryForms, strengths and routes
Source: NDC DirectoryPharmacologic classes are listed in the class section below.
Pharmacologic class
Source: NDC Directory| Class | Type | Browse |
|---|---|---|
| Polyene Antifungal [EPC] | EPC | All 12 members |
| Polyenes [CS] | CS | All 13 members |
Regulatory status
Source: Drugs@FDANDC Directory| Product | Trade name | Form | Strength | Ingredient | Status | TE | Flags |
|---|---|---|---|---|---|---|---|
| 062225-001 | NYSTATIN | CREAM | NYSTATIN | Prescription | AT |
Therapeutic equivalence
Source: Orange BookWhat this rating means: Therapeutically equivalent — bioequivalence demonstrated (topical dermatological products)
Codes beginning with “A” indicate products the FDA considers therapeutically equivalent. Codes beginning with “B” indicate bioequivalence has not been established. See methodology.
Approval history
Source: Drugs@FDA| Type | No. | Action | Status | Date | Review |
|---|---|---|---|---|---|
| Supplement | 11 | Labeling | Approved | December 3, 2009 | — |
| Supplement | 10 | Labeling | Approved | April 17, 2009 | — |
| Supplement | 8 | Manufacturing (CMC) | Approved | September 5, 2000 | — |
| Supplement | 7 | Manufacturing (CMC) | Approved | June 15, 1995 | — |
| Supplement | 6 | Manufacturing (CMC) | Approved | June 15, 1995 | — |
| Supplement | 4 | Labeling | Approved | July 6, 1994 | — |
| Supplement | 5 | Labeling | Approved | October 4, 1993 | — |
| Supplement | 3 | Manufacturing (CMC) | Approved | March 18, 1988 | — |
| Original application | 1 | Approved | December 11, 1979 | — |
Prescribing information
Source: openFDA Drug LabelingReproduced verbatim from the Structured Product Labeling submitted to the FDA (effective 20260706). This is the manufacturer's labelling text, not a summary and not advice.
Indications and Usage
openFDA Drug LabelingINDICATIONS AND USAGE Nystatin Cream USP is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by Candida albicans and other susceptible Candida species. Nystatin Cream USP is not indicated for systemic, oral, intravaginal or ophthalmic use.
Dosage and Administration
openFDA Drug LabelingDOSAGE AND ADMINISTRATION Very moist lesions are best treated with nystatin topical dusting powder. Adults and Pediatric Patients (Neonates and Older): Apply liberally to affected areas twice daily or as indicated until healing is complete.
Contraindications
openFDA Drug LabelingCONTRAINDICATIONS Nystatin Cream USP is contraindicated in patients with a history of hypersensitivity to any of its components.
Adverse Reactions
openFDA Drug LabelingADVERSE REACTIONS The frequency of adverse events reported in patients using nystatin cream is less than 0.1%. The more common events that were reported include allergic reactions, burning, itching, rash, eczema, and pain on application. (See PRECAUTIONS: General . ) To report SUSPECTED ADVERSE REACTIONS, contact Cosette Pharmaceuticals, Inc. at 1-800-922-1038 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch .
Description
openFDA Drug LabelingDESCRIPTION Nystatin is a polyene antifungal antibiotic obtained from Streptomyces nursei . Structural formula: C47H75NO17 Molecular Weight: 926.13 Nystatin cream is for dermatologic use. Nystatin cream for topical use, contains 100,000 USP nystatin units per gram in an aqueous, perfumed cream base containing aluminum hydroxide gel, ceteareth-15, glyceryl monostearate, polyethylene glycol 400 monostearate, propylene glycol, purified water, simethicone emulsion, sorbitol solution, titanium dioxide, white petrolatum, with methylparaben and propylparaben as preservatives and, if necessary, sodium hydroxide for pH adjustment. Chemical Structure
How Supplied / Storage and Handling
openFDA Drug LabelingHOW SUPPLIED Nystatin Cream USP is a yellow to light green cream. It is supplied as: 15 gram Tube NDC 68788-4099-1 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Avoid freezing. Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540 Manufacturer: Macleods Pharmaceuticals Limited At Oxalis Labs Baddi, Himachal Pradesh, INDIA Rev. 08/2021 Relabeled By: Preferred Pharmaceuticals Inc.
Adverse event reports
Source: openFDA FAERSAttributed to this product's most-reported active ingredient: NYSTATIN. Combination products with more than six active ingredients are not attributed, because a report count summed across a long ingredient list measures the list, not the medicine.
Recalls
Source: FDA Enforcement| Classification | Reported | Firm | Reason | Status |
|---|---|---|---|---|
| Class II | July 22, 2026 | Padagis US LLC | Subpotent Drug: Low out of specification assay results performed during long-term stability testing. | Ongoing |
Packaging and NDCs
Source: NDC Directory| Package NDC | Product NDC | Labeler | Description | Marketing start |
|---|---|---|---|---|
| 50090-2763-0 | 50090-2763 | A-S Medication Solutions | 1 TUBE in 1 CARTON (50090-2763-0) / 30 g in 1 TUBE | January 9, 2017 |
| 50090-2854-0 | 50090-2854 | A-S Medication Solutions | 1 TUBE in 1 CARTON (50090-2854-0) / 15 g in 1 TUBE | February 8, 2017 |
| 50090-3772-0 | 50090-3772 | A-S Medication Solutions | 1 TUBE in 1 CARTON (50090-3772-0) / 30 g in 1 TUBE | November 5, 2018 |
| 50090-3799-0 | 50090-3799 | A-S Medication Solutions | 1 TUBE in 1 CARTON (50090-3799-0) / 15 g in 1 TUBE | November 8, 2018 |
| 50090-7303-0 | 50090-7303 | A-S Medication Solutions | 15 g in 1 TUBE (50090-7303-0) | October 14, 2024 |
| 59651-907-14 | 59651-907 | Aurobindo Pharma Limited | 1 TUBE in 1 CARTON (59651-907-14) / 15 g in 1 TUBE | March 21, 2025 |
| 59651-907-30 | 59651-907 | Aurobindo Pharma Limited | 1 TUBE in 1 CARTON (59651-907-30) / 30 g in 1 TUBE | March 21, 2025 |
| 63629-8694-1 | 63629-8694 | Bryant Ranch Prepack | 1 TUBE in 1 CARTON (63629-8694-1) / 15 g in 1 TUBE | January 25, 2007 |
| 63629-8695-1 | 63629-8695 | Bryant Ranch Prepack | 1 TUBE in 1 CARTON (63629-8695-1) / 30 g in 1 TUBE | September 21, 2006 |
| 71335-2830-1 | 71335-2830 | Bryant Ranch Prepack | 1 TUBE in 1 CARTON (71335-2830-1) / 30 g in 1 TUBE | October 23, 2025 |
| 72162-1385-2 | 72162-1385 | Bryant Ranch Prepack | 1 TUBE in 1 CARTON (72162-1385-2) / 15 g in 1 TUBE | April 2, 2025 |
| 72162-1385-3 | 72162-1385 | Bryant Ranch Prepack | 1 TUBE in 1 CARTON (72162-1385-3) / 30 g in 1 TUBE | April 2, 2025 |
| 72162-2496-2 | 72162-2496 | Bryant Ranch Prepack | 1 TUBE in 1 CARTON (72162-2496-2) / 15 g in 1 TUBE | May 15, 2025 |
| 72162-2496-3 | 72162-2496 | Bryant Ranch Prepack | 1 TUBE in 1 CARTON (72162-2496-3) / 30 g in 1 TUBE | May 15, 2025 |
| 72162-2576-2 | 72162-2576 | Bryant Ranch Prepack | 15 g in 1 TUBE (72162-2576-2) | November 17, 2025 |
| 72162-2576-3 | 72162-2576 | Bryant Ranch Prepack | 30 g in 1 TUBE (72162-2576-3) | November 17, 2025 |
| 0713-0678-15 | 0713-0678 | Cosette Pharmaceuticals, Inc. | 1 TUBE in 1 CARTON (0713-0678-15) / 15 g in 1 TUBE | April 1, 2015 |
| 0713-0678-31 | 0713-0678 | Cosette Pharmaceuticals, Inc. | 1 TUBE in 1 CARTON (0713-0678-31) / 30 g in 1 TUBE | April 1, 2015 |
| 72189-278-15 | 72189-278 | DIRECT RX | 15 g in 1 BOX (72189-278-15) | September 30, 2021 |
| 33342-469-15 | 33342-469 | Macleods Pharmaceuticals Limited | 1 TUBE in 1 CARTON (33342-469-15) / 15 g in 1 TUBE | August 25, 2021 |
| 33342-469-30 | 33342-469 | Macleods Pharmaceuticals Limited | 1 TUBE in 1 CARTON (33342-469-30) / 30 g in 1 TUBE | August 25, 2021 |
| 68071-3911-5 | 68071-3911 | NuCare Pharmaceuticals, Inc. | 1 TUBE in 1 CARTON (68071-3911-5) / 15 g in 1 TUBE | November 6, 2025 |
| 66267-952-30 | 66267-952 | NuCare Pharmaceuticals,Inc. | 30 g in 1 BOX (66267-952-30) | August 24, 2017 |
| 66267-953-15 | 66267-953 | NuCare Pharmaceuticals,Inc. | 15 g in 1 BOX (66267-953-15) | April 18, 2019 |
| 68071-2556-5 | 68071-2556 | NuCare Pharmaceuticals,Inc. | 1 TUBE in 1 CARTON (68071-2556-5) / 15 g in 1 TUBE | October 28, 2021 |
| 68071-4293-3 | 68071-4293 | NuCare Pharmaceuticals,Inc. | 30 g in 1 BOX (68071-4293-3) | February 20, 2018 |
| 45802-059-11 | 45802-059 | Padagis Israel Pharmaceuticals Ltd | 1 TUBE in 1 CARTON (45802-059-11) / 30 g in 1 TUBE | September 21, 2006 |
| 45802-059-35 | 45802-059 | Padagis Israel Pharmaceuticals Ltd | 1 TUBE in 1 CARTON (45802-059-35) / 15 g in 1 TUBE | January 25, 2007 |
| 68788-4099-1 | 68788-4099 | Preferred Pharmaceuticals Inc. | 1 TUBE in 1 CARTON (68788-4099-1) / 15 g in 1 TUBE | July 6, 2026 |
| 68788-8631-1 | 68788-8631 | Preferred Pharmaceuticals Inc. | 15 g in 1 TUBE (68788-8631-1) | April 15, 2024 |
| 68788-8631-3 | 68788-8631 | Preferred Pharmaceuticals Inc. | 30 g in 1 TUBE (68788-8631-3) | April 15, 2024 |
| 63187-703-15 | 63187-703 | Proficient Rx LP | 1 TUBE in 1 CARTON (63187-703-15) / 15 g in 1 TUBE | June 1, 2016 |
| 63187-703-30 | 63187-703 | Proficient Rx LP | 1 TUBE in 1 CARTON (63187-703-30) / 30 g in 1 TUBE | June 1, 2016 |
| 63187-847-15 | 63187-847 | Proficient Rx LP | 1 TUBE in 1 CARTON (63187-847-15) / 15 g in 1 TUBE | May 1, 2017 |
| 63187-847-30 | 63187-847 | Proficient Rx LP | 1 TUBE in 1 CARTON (63187-847-30) / 30 g in 1 TUBE | May 1, 2017 |
| 71205-723-30 | 71205-723 | Proficient Rx LP | 1 TUBE in 1 CARTON (71205-723-30) / 30 g in 1 TUBE | November 17, 2022 |
| 82804-045-15 | 82804-045 | Proficient Rx LP | 15 g in 1 TUBE (82804-045-15) | December 8, 2023 |
| 82804-045-30 | 82804-045 | Proficient Rx LP | 30 g in 1 TUBE (82804-045-30) | December 8, 2023 |
| 67296-1519-1 | 67296-1519 | RedPharm Drug, Inc | 15 g in 1 TUBE (67296-1519-1) | July 24, 2019 |
| 67296-1519-3 | 67296-1519 | RedPharm Drug, Inc | 30 g in 1 TUBE (67296-1519-3) | July 24, 2019 |
| 51672-1289-1 | 51672-1289 | Sun Pharmaceutical Industries, Inc. | 1 TUBE in 1 CARTON (51672-1289-1) / 15 g in 1 TUBE | January 28, 1993 |
| 51672-1289-2 | 51672-1289 | Sun Pharmaceutical Industries, Inc. | 1 TUBE in 1 CARTON (51672-1289-2) / 30 g in 1 TUBE | January 28, 1993 |
| 13668-595-01 | 13668-595 | Torrent Pharmaceuticals Limited | 15 g in 1 TUBE (13668-595-01) | July 24, 2019 |
| 13668-595-02 | 13668-595 | Torrent Pharmaceuticals Limited | 30 g in 1 TUBE (13668-595-02) | July 24, 2019 |
| 50090-2763 | 50090-2763 | A-S Medication Solutions | — | September 21, 2006 |
| 50090-2854 | 50090-2854 | A-S Medication Solutions | — | September 21, 2006 |
| 50090-3772 | 50090-3772 | A-S Medication Solutions | — | April 1, 2015 |
| 50090-3799 | 50090-3799 | A-S Medication Solutions | — | April 1, 2015 |
| 50090-7303 | 50090-7303 | A-S Medication Solutions | — | July 24, 2019 |
| 59651-907 | 59651-907 | Aurobindo Pharma Limited | — | March 21, 2025 |
| 63629-8694 | 63629-8694 | Bryant Ranch Prepack | — | September 21, 2006 |
| 63629-8695 | 63629-8695 | Bryant Ranch Prepack | — | September 21, 2006 |
| 71335-2830 | 71335-2830 | Bryant Ranch Prepack | — | September 21, 2006 |
| 72162-1385 | 72162-1385 | Bryant Ranch Prepack | — | September 21, 2006 |
| 72162-2496 | 72162-2496 | Bryant Ranch Prepack | — | August 25, 2021 |
| 72162-2576 | 72162-2576 | Bryant Ranch Prepack | — | July 24, 2019 |
| 0713-0678 | 0713-0678 | Cosette Pharmaceuticals, Inc. | — | April 1, 2015 |
| 72189-278 | 72189-278 | DIRECT RX | — | September 30, 2021 |
| 33342-469 | 33342-469 | Macleods Pharmaceuticals Limited | — | August 25, 2021 |
| 68071-3911 | 68071-3911 | NuCare Pharmaceuticals, Inc. | — | April 1, 2015 |
| 66267-952 | 66267-952 | NuCare Pharmaceuticals,Inc. | — | January 28, 1993 |
| 66267-953 | 66267-953 | NuCare Pharmaceuticals,Inc. | — | September 21, 2006 |
| 68071-2556 | 68071-2556 | NuCare Pharmaceuticals,Inc. | — | January 28, 1993 |
| 68071-4293 | 68071-4293 | NuCare Pharmaceuticals,Inc. | — | September 21, 2006 |
| 45802-059 | 45802-059 | Padagis Israel Pharmaceuticals Ltd | — | September 21, 2006 |
| 68788-4099 | 68788-4099 | Preferred Pharmaceuticals Inc. | — | July 6, 2026 |
| 68788-8631 | 68788-8631 | Preferred Pharmaceuticals Inc. | — | April 15, 2024 |
| 63187-703 | 63187-703 | Proficient Rx LP | — | January 28, 1993 |
| 63187-847 | 63187-847 | Proficient Rx LP | — | September 21, 2006 |
| 71205-723 | 71205-723 | Proficient Rx LP | — | April 1, 2015 |
| 82804-045 | 82804-045 | Proficient Rx LP | — | July 24, 2019 |
| 67296-1519 | 67296-1519 | RedPharm Drug, Inc | — | July 24, 2019 |
| 51672-1289 | 51672-1289 | Sun Pharmaceutical Industries, Inc. | — | January 28, 1993 |
| 13668-595 | 13668-595 | Torrent Pharmaceuticals Limited | — | July 24, 2019 |
Sources for this page
| Dataset | Agency | Used for |
|---|---|---|
| NDC Directory | FDA | Identity, ingredients, strengths, forms, routes, labelers, packages |
| Drugs@FDA | FDA | Application, sponsor, submissions, review documents, marketing status |
| Orange Book | FDA | Therapeutic equivalence codes, reference drug flags, patents, exclusivity |
| Drug Labeling | FDA / NLM | Prescribing information reproduced above |
| FAERS | FDA | Adverse event report counts |
| Enforcement | FDA | Recall records |
Generated September 25, 2026 · 13 sections on this page.